DOH targets 735,631 kids for vaccination vs COVID-19 in Eastern Visayas | Inquirer News

DOH targets 735,631 kids for vaccination vs COVID-19 in Eastern Visayas

/ 06:04 PM February 09, 2022

TACLOBAN CITY — At least 735,631 children in Eastern Visayas need to be vaccinated against COVID-19, the Department of Health (DOH) said.

Jelyn Lopez Malibago, DOH regional information officer, said the vaccination for children aged 5 to 11 in the region would start on Feb. 14.

Leyte province has the highest number of children to be vaccinated with 319,203, followed by Samar (132,063), Northern Samar (112,274), Eastern Samar (80,640), Southern Leyte (64,233, and Biliran province (27,218).

Article continues after this advertisement

This early, the DOH, through various local governments, is preparing for the inoculation of children using the Pfizer brand.

“The vaccine is safe, effective, and free. So we encourage everyone to join us in our campaign to vaccinate our children aged five to 11 years old,” Malibago said.

lzb
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: Children, COVID-19, DoH

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.